Stockscreener 앱 받기
309.87
0.77%
-2.41
시간 외 거래:
309.87
전일 마감가:
$312.28
열려 있는:
$313.32
하루 거래량:
1.08M
Relative Volume:
0.79
시가총액:
$59.13B
수익:
$328.68B
순이익/손실:
$2.55B
주가수익비율:
23.77
EPS:
13.0349
순현금흐름:
$1.56B
1주 성능:
+0.15%
1개월 성능:
-4.29%
6개월 성능:
-5.32%
1년 성능:
+0.49%
1일 변동 폭
$309.18
$316.61
1주일 범위
$304.45
$320.24
52주 변동 폭
$244.82
$377.54
Cencora Inc Stock (COR) Company Profile
명칭
Cencora Inc
전화
610-727-7000
주소
1 WEST FIRST AVENUE, CONSHOHOCKEN
Compare COR vs MCK, CAH, HSIC, AHG
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
COR
Cencora Inc
|
309.87 | 59.59B | 328.68B | 2.55B | 1.56B | 13.03 |
MCK
Mckesson Corp
|
869.36 | 102.66B | 403.43B | 5.10B | 5.41B | 38.47 |
CAH
Cardinal Health Inc
|
222.62 | 51.24B | 250.74B | 1.55B | 4.39B | 6.5398 |
HSIC
Henry Schein Inc
|
85.53 | 9.48B | 13.38B | 418.00M | 391.00M | 3.3112 |
AHG
Akso Health Group Adr
|
0.76 | 659.58M | 14.85M | -136.07M | 7.25M | -0.4726 |
Cencora Inc Stock (COR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-01-29 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2026-01-22 | 업그레이드 | Jefferies | Hold → Buy |
| 2025-12-09 | 개시 | Barclays | Overweight |
| 2025-06-03 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2024-12-04 | 재개 | Mizuho | Outperform |
| 2024-09-18 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2024-02-26 | 개시 | Leerink Partners | Outperform |
| 2024-01-03 | 개시 | Barclays | Overweight |
| 2023-12-14 | 개시 | Wells Fargo | Equal Weight |
| 2023-03-31 | 개시 | Citigroup | Buy |
| 2023-01-31 | 재개 | Evercore ISI | Outperform |
| 2022-10-11 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2022-08-22 | 재개 | Morgan Stanley | Equal-Weight |
| 2022-07-11 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2022-06-07 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2022-05-26 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2022-04-12 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2022-04-01 | 재개 | Credit Suisse | Outperform |
| 2021-03-12 | 재개 | Evercore ISI | In-line |
| 2021-02-04 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2021-02-02 | 업그레이드 | Cowen | Market Perform → Outperform |
| 2021-01-06 | 업그레이드 | BofA Securities | Underperform → Neutral |
| 2021-01-06 | 업그레이드 | Credit Suisse | Neutral → Outperform |
| 2020-12-10 | 다운그레이드 | Wells Fargo | Equal Weight → Underweight |
| 2020-12-03 | 개시 | Mizuho | Neutral |
| 2020-08-06 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2020-07-15 | 개시 | Barclays | Underweight |
| 2020-06-15 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2020-04-23 | 재개 | Credit Suisse | Outperform |
| 2020-04-16 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2020-04-13 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2020-04-01 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2020-03-17 | 업그레이드 | Citigroup | Neutral → Buy |
| 2020-02-11 | 다운그레이드 | BofA/Merrill | Buy → Underperform |
| 2020-02-07 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2019-09-12 | 개시 | Deutsche Bank | Hold |
| 2019-07-10 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2019-04-11 | 개시 | Guggenheim | Buy |
| 2019-04-10 | 다운그레이드 | BofA/Merrill | Buy → Underperform |
| 2019-04-10 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2019-02-11 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2019-01-17 | 개시 | UBS | Buy |
| 2018-12-10 | 다운그레이드 | Jefferies | Buy → Hold |
| 2018-10-26 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2018-09-20 | 개시 | Berenberg | Buy |
| 2018-07-17 | 재개 | Stifel | Hold |
| 2018-04-09 | 개시 | MoffettNathanson | Buy |
| 2018-03-12 | 업그레이드 | KeyBanc Capital Mkts | Sector Weight → Overweight |
| 2018-03-12 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2017-09-25 | 개시 | JP Morgan | Neutral |
| 2017-09-22 | 개시 | William Blair | Outperform |
모두보기
Cencora Inc 주식(COR)의 최신 뉴스
Cencora (COR) Conference Updates Keep Undervalued Case In Focus - simplywall.st
Cencora stock trades at USD 314.64 below its yearly high - ad-hoc-news.de
Cencora stock holds near USD 316 after strong quarterly results - ad-hoc-news.de
Cencora stock holds at USD 308.78 as specialty growth supports outlook - ad-hoc-news.de
Cencora stock heads into the open after a 1.5 percent market-led gain - ad-hoc-news.de
Cencora stock gains as specialty strategy supports fiscal 2027 outlook - ad-hoc-news.de
Cencora Sees Specialty Strategy Fueling Growth Into Fiscal 2027 - finance.yahoo.com
Cencora Inc. stock outperforms competitors on strong trading day - MarketWatch
Cencora Highlights Specialty Growth, MSO Expansion and Walgreens Ties at Conference - finance.yahoo.com
Cencora, Inc. (COR) Stock Analysis: Unveiling a 19.6% Potential Upside in the Healthcare Distribution Sector - directorstalkinterviews.com
Cencora (COR) Lifts EPS Outlook And Buyback, Is The Stock Still Below Fair Value? - finance.yahoo.com
Cencora Inc. stock gains after raising full-year EPS guidance - ad-hoc-news.de
Cencora (COR) Raised Guidance and Bought Back $1B. What’s the Catch? - finance.yahoo.com
What Makes the Latest Cencora (COR) Story Different? - Kalkine Media
Cencora Inc. stock eases after insider sale while earnings grow - ad-hoc-news.de
Cencora Inc. stock eases after recent insider share sale - AD HOC NEWS
Cencora, Inc. (COR) Stock Forecasts - finance.yahoo.com
Cencora (NYSE: COR) director sells $411K in shares - Stock Titan
Cencora Inc. stock gains after beating quarterly earnings estimates - AD HOC NEWS
Cencora Inc Hired Firms, 2026 - OpenSecrets
Cencora (NYSE: COR) director files notice for potential stock sale via Merrill Lynch - Stock Titan
Cencora, Inc. (COR) Stock Analysis: Strong Buy Ratings And A 14.85% Upside Potential - directorstalkinterviews.com
$1000 Invested In Cencora 10 Years Ago Would Be Worth This Much Today - benzinga.com
Cencora (COR) ex-officer lines up new stock sale - Stock Titan
Cencora (COR) Stock Forecast and Price Target 2026 $COR - MarketBeat
Cencora stock heads into the open after a 0.1% dip - ad-hoc-news.de
Is Cencora (COR) Still Undervalued On Higher 2026 Guidance And Strong Q3 Earnings? - Yahoo Finance
Cencora Inc. stock dips after RBC reiterates cautious price target - ad-hoc-news.de
Is Cencora Stock Underperforming the Dow? - Yahoo Finance
Cencora stock price target maintained at $330 by RBC Capital By Investing.com - Investing.com Australia
Cencora stock heads into the open after a modest decline - ad-hoc-news.de
Cencora stock holds firm after RBC keeps $330 target - ad-hoc-news.de
Cencora Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Cencora stock price target maintained at $330 by RBC Capital - Investing.com Canada
Cencora, Inc. (COR) Stock Analysis: Robust Growth in Medical Distribution with an 11.59% Upside Potential - DirectorsTalk Interviews
Cencora Inc. stock gains on solid fiscal 2026 momentum - ad-hoc-news.de
Why Cencora (COR) Is Getting Attention Today - simplywall.st
Cencora’s New Cell and Gene Services Might Change The Case For Investing In Cencora (COR) - simplywall.st
Cencora Inc. stock underperforms Friday when compared to competitors - MarketWatch
Here's Why You Should Retain Cencora Stock in Your Portfolio for Now - Yahoo Finance
AbbVie vs. Pfizer: Which Healthcare Stock Is a Better Buy in 2026? - The Motley Fool
Former Cencora (NYSE: COR) leader lines up another stock sale - Stock Titan
Cencora Inc. stock gains on new cell and gene therapy service and strong guidance - ad-hoc-news.de
Cencora (COR) Up 3.8% Since Last Earnings Report: Can It Continue? - Yahoo Finance
Cencora Launches Cell and Gene Therapy Enablement for Health Systems - Yahoo Finance
Cencora (COR) Unveils Cell And Gene Therapy Enablement Service - simplywall.st
What Cencora (COR)'s Cell and Gene Push and Higher 2026 Outlook Means For Shareholders - Yahoo Finance
Cencora Raises 2026 EPS Outlook as Specialty Businesses Strengthen - Yahoo Finance
Cencora Launches Cell and Gene Therapy Enablement to Help Health Systems Build and Scale Programs - BioBuzz
Artisan Sold Cencora (COR) as Earnings Momentum Slowed - Yahoo Finance
Cencora (NYSE: COR) executive sells 985 shares in preset plan - Stock Titan
Cencora Inc (COR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.61%
1.27%
자본화:
|
볼륨(24시간):